Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands

Completed · Not applicable

Conditions studied: Cancer Colon

In brief

This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.

Key facts

Study ID: NCT06119425
Run by: Ballad Health
People needed: 231
Starts: 2023-10-12
Expected to finish: 2025-04-30
Last updated by the study team: 2026-02-10

Who can join

Age: 45 and older, up to 84. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Patients aged 45-84 years of age (inclusive)
Considered by health-care providers to be "average risk" for CRC as determined by USPSTF guidelines
If a patient opts for blood-based test, they are able and willing to provide blood samples per protocol
Ability to understand and the willingness to participate in the study

You may not qualify if…

Patients with a personal history of CRC
Patients with a known high-risk family history of CRC precluding the patient from being average risk
Patients with known diagnosis of inflammatory bowel disease or history of polyps
Patients who are currently symptomatic for CRC such as: blood in the stool
Patients with any known medical condition which, in the opinion of the investigator, should preclude enrollment into the study
Have a recorded up to date CRC screening
Patients with a previous abnormal colonoscopy finding who are due for surveillance.

Where it is running

Johnson City Medical Center — Johnson City, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.